Ivermectin-facilitated immunity in onchocerciasis; activation of parasite-specific Th1-type responses with subclinical Onchocerca volvulus infection
- PMID: 8187332
- PMCID: PMC1534906
- DOI: 10.1111/j.1365-2249.1994.tb06548.x
Ivermectin-facilitated immunity in onchocerciasis; activation of parasite-specific Th1-type responses with subclinical Onchocerca volvulus infection
Abstract
The present study examined the quantitative and qualitative changes registered in the parasite-specific antibody response, cellular reactivity and cytokine production profile in onchocerciasis patients repeatedly treated with ivermectin over a period of 8 years. The densities of Onchocerca volvulus microfilariae (mf) in treated patients remained significantly reduced, whereas the number of permanently amicrofilaridermic patients (subclinical infection) increased with repeated treatments. In vitro cellular responses to O. volvulus antigen (OvAg) were highest (P < 0.01) in untreated control individuals exposed to infection, but negative for mf of O. volvulus (endemic normals). Cellular reactivity in repeatedly treated patients was higher at 84 than at 36 months post initial treatment (p.i.t); furthermore, the proliferative responses to OvAg, mycobacterial purified protein derivative (PPD) and streptococcal SL-O were greater (P < 0.05) at 84 months p.i.t. in amicrofilaridermic than in microfilaria-positive onchocerciasis patients. In amicrofilaridermic patients such reactivity approached the magnitude observed in endemic normals. Peripheral blood mononuclear cells (PBMC) from patients and endemic normals produced equivalent amounts of IL-2, IL-4 and interferon-gamma (IFN-gamma) in response to mitogenic stimulation with phytohaemagglutinin (PHA); in response to OvAg, however, significantly more IL-2 and IFN-gamma were produced by PBMC from subclinical amicrofilaridermic patients or endemic normals than by mf-positive patients. OvAg-specific production of IL-4 by PBMC from treated patients was lower at 84 than at 36 months p.i.t. At three months p.i.t. the titres of circulating OvAg-specific IgG1-3 had increased (P < 0.05), but they then continuously declined with repeated treatments. Only IgG1 and IgG4 bound to OvAg of mol. wt 2-12 kD at 1 month p.i.t., while recognition of OvAg of mol. wt 10-200 kD by IgG1, IgG2 and IgG4 reached a maximum intensity at 3-6 months p.i.t., with the overall intensity of binding to OvAg gradually weakening thereafter. These results suggest that onchocerciasis-associated immunosuppression is reversible following ivermectin-induced permanent clearance of microfilariae from the skin; and that a vigorous parasite-specific cellular reactivity and a sustained production of IL-2 and IFN-gamma in amicrofilaridermic individuals may contribute to controlling O. volvulus infection.
Similar articles
-
The diverse expression of immunity in humans at distinct states of Onchocerca volvulus infection.Immunology. 1997 Apr;90(4):592-9. doi: 10.1046/j.1365-2567.1997.00210.x. Immunology. 1997. PMID: 9176114 Free PMC article.
-
Immunoregulation in onchocerciasis: predominance of Th1-type responsiveness to low molecular weight antigens of Onchocerca volvulus in exposed individuals without microfilaridermia and clinical disease.Clin Exp Immunol. 1996 Aug;105(2):245-53. doi: 10.1046/j.1365-2249.1996.d01-747.x. Clin Exp Immunol. 1996. PMID: 8706329 Free PMC article.
-
Onchocerca volvulus-specific antibody and cytokine responses in onchocerciasis patients after 16 years of repeated ivermectin therapy.Clin Exp Immunol. 2007 Mar;147(3):504-12. doi: 10.1111/j.1365-2249.2006.03312.x. Clin Exp Immunol. 2007. PMID: 17302900 Free PMC article.
-
CD4+-dependent immunity to Onchocerca volvulus third-stage larvae in humans and the mouse vaccination model: common ground and distinctions.Int J Parasitol. 2003 Sep 30;33(11):1161-71. doi: 10.1016/s0020-7519(03)00170-x. Int J Parasitol. 2003. PMID: 13678632 Review.
-
Onchocerca volvulus infections in chimpanzees: an assessment of the requirements for vaccination trials.J Helminthol. 1994 Mar;68(1):3-6. doi: 10.1017/s0022149x00013390. J Helminthol. 1994. PMID: 8006381 Review. No abstract available.
Cited by
-
Density-dependent mortality of the human host in onchocerciasis: relationships between microfilarial load and excess mortality.PLoS Negl Trop Dis. 2012;6(3):e1578. doi: 10.1371/journal.pntd.0001578. Epub 2012 Mar 27. PLoS Negl Trop Dis. 2012. PMID: 22479660 Free PMC article.
-
Protective responses against skin-dwelling microfilariae of Onchocerca lienalis in severe combined immunodeficient mice.Infect Immun. 1997 Jul;65(7):2846-51. doi: 10.1128/iai.65.7.2846-2851.1997. Infect Immun. 1997. PMID: 9199458 Free PMC article.
-
Examining the role of macrolides and host immunity in combatting filarial parasites.Parasit Vectors. 2017 Apr 14;10(1):182. doi: 10.1186/s13071-017-2116-6. Parasit Vectors. 2017. PMID: 28410595 Free PMC article. Review.
-
Designing and comparative analysis of anti-oxidant and heat shock proteins based multi-epitopic filarial vaccines.BMC Infect Dis. 2024 Dec 18;24(1):1436. doi: 10.1186/s12879-024-10272-9. BMC Infect Dis. 2024. PMID: 39695454 Free PMC article.
-
Decreased CD4 and increased CD8 counts with T cell activation is associated with chronic helminth infection.Clin Exp Immunol. 1998 Dec;114(3):414-21. doi: 10.1046/j.1365-2249.1998.00736.x. Clin Exp Immunol. 1998. PMID: 9844052 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources